ClinicalTrials.gg
Not yet recruitingNCT07873515Updated Oct 16, 2026

Effects of Action Observation and Motor Imagery on PNF Skill Learning in Physiotherapy Students

An interventional study of Motor Imagery Practice and Action Observation Practice in Motor Skill Learning, sponsored by Antalya Bilim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Antalya Bilim University · Not applicable, Interventional, and Other

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

his randomized controlled trial aims to investigate the effects of action observation and motor imagery on short- and long-term learning of Proprioceptive Neuromuscular Facilitation (PNF) skills, perceived mental fatigue, and task difficulty in physiotherapy students.

A total of 24 second-year physiotherapy students will be randomly allocated to three groups: motor imagery, action observation, and conventional learning (control). PNF performance will be assessed using performance scores and task completion time immediately after the intervention, 1 hour later, and 24 hours later.

Read the detailed description

This single-blind, randomized controlled trial aims to investigate the effects of action observation and motor imagery on the short- and long-term learning of Proprioceptive Neuromuscular Facilitation (PNF) skills in physiotherapy students.

A total of 24 second-year physiotherapy students will be randomly allocated to three parallel groups (n=8 per group): motor imagery, action observation, and conventional learning (control). All participants will receive standardized instructions regarding the selected PNF task before the intervention.

The motor imagery group will mentally rehearse the PNF movements from a first-person perspective without physical execution. The action observation group will observe a video demonstration of the PNF task performed by a physiotherapist. The control group will physically practice the PNF task under physiotherapist supervision. Each intervention will consist of 10 repetitions lasting 60 seconds, with a one-minute rest period after every two repetitions.

PNF performance will be assessed using performance scores and task completion time at three time points: immediately post-intervention (T0), 1 hour post-intervention (T1), and 24 hours post-intervention (T2). Performance will be video-recorded and evaluated by an experienced physiotherapist blinded to group allocation.

Perceived mental fatigue and task difficulty will be assessed using visual analog scales (VAS). Motor imagery ability will also be evaluated using the Movement Imagery Questionnaire-3 (MIQ-3) and mental chronometry.

The study aims to determine whether action observation and motor imagery provide benefits for PNF skill acquisition and retention compared with conventional learning.

02

Conditions studied

  • Motor Skill Learning

Keywords

  • Proprioceptive Neuromuscular Facilitation
  • Motor Imagery
  • Action Observation
  • Motor Learning
  • Physiotherapy Education
  • Skill Retention
03

In context

Lead sponsor

Antalya Bilim University is the lead sponsor of 15 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being older than 18 years.
  • Being a second-year student in the Department of Physiotherapy and Rehabilitation at Antalya Bilim University.
  • Being able to speak and understand Turkish.

Exclusion criteria

Exclusion Criteria:

  • Having a neurological, musculoskeletal, cardiovascular, pulmonary, or metabolic disease that prevents participation in the study.
  • Experiencing any pain at the time of the study.
  • Having previously participated in a study investigating motor imagery.
  • Using medications that affect attention or alertness.
  • Having a psychological disorder that affects attention or alertness.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Motor Imagery Group

    Participants will mentally rehearse the PNF task from a first-person perspective without physically performing the movements.

    Behavioral: Motor Imagery Practice

  • Experimental
    Action Observation Group

    Participants will observe a video demonstration of the PNF task performed by a physiotherapist without physically executing the movements.

    Behavioral: Action Observation Practice

  • Active comparator
    Conventional Learning Group

    Participants will physically practice the PNF task under the guidance of a physiotherapist using the conventional learning approach.

    Behavioral: Conventional PNF Practice

Interventions

  • BehavioralMotor Imagery Practice

    Participants will mentally rehearse the PNF task from a first-person perspective without physical execution.

  • BehavioralAction Observation Practice

    Participants will observe a video demonstration of the PNF task performed by a physiotherapist without physically executing the movements.

  • BehavioralConventional PNF Practice

    Participants will physically practice the PNF task under the supervision of a physiotherapist using the conventional learning approach.

06

What researchers measure

Primary outcomes

  1. PNF Performance Score

    PNF skills will be evaluated using a performance scoring checklist (0-14 points), with higher scores indicating better performance.

    Time frame: Immediately, 1 hour, and 24 hours post-intervention

  2. PNF Task Completion Time

    Time required to complete the PNF task, measured in seconds.

    Time frame: Immediately, 1 hour, and 24 hours post-intervention

Secondary outcomes

  1. Perceived Mental Fatigue

    Perceived mental fatigue will be assessed using a Visual Analog Scale (VAS) ranging from 0 (no mental fatigue) to 10 (maximum imaginable mental fatigue). Participants will be asked to mark the point on the line that best represents their perceived level of mental fatigue. Higher scores indicate greater perceived mental fatigue (worse outcome).

    Time frame: Immediately, 1 hour, and 24 hours post-intervention

  2. Perceived Task Difficulty

    Perceived task difficulty will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no difficulty) to 10 (maximum imaginable difficulty). Participants will mark their perceived task difficulty on the scale, and the distance from the left endpoint to the mark will be measured in centimeters. Higher scores indicate greater perceived task difficulty (worse outcome).

    Time frame: Immediately, 1 hour, and 24 hours post-intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Nov 2026, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2026
First posted
Oct 14, 2026
StartEst.
Oct 12, 2026
Primary completionEst.
Nov 12, 2026
CompletionEst.
Nov 12, 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Secondary outcomes
2 description edited
What changed in the outcomes
  • DescriptionPerceived Mental Fatigue: how it is measured was reworded
  • DescriptionPerceived Task Difficulty: how it is measured was reworded
Oct 16, 2026
Registered
First appeared on the registry
Oct 14, 2026
Show all 2 updates
  1. Oct 16, 2026
    Secondary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionPerceived Mental Fatigue: how it is measured was reworded
    • DescriptionPerceived Task Difficulty: how it is measured was reworded
  2. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07873515
Lead sponsor
Antalya Bilim University
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Oct 12, 2026 (estimated)
Primary completion
Nov 12, 2026 (estimated)
Completion
Nov 12, 2026 (estimated)
Last update
Oct 16, 2026

Study contacts

Merve Ünal, MSc
Contact
merveunal@antalya.edu.tr
02422450000/3314
Merve Ünal, MSc
principal investigator · Antalya Bilim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion